Evaluation of prostatic massage in treatment of chronic prostatitis

Ateya, A. A.; Fayez, Ashraf; Hani, Ragab; Zohdy, Wael; Gabbar, Mohammad A.; Shamloul, Rany

doi:10.1016/j.urology.2005.10.021

Cited by 33 publications

(21 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, it should be noted that bacteria adhering to the prostatic ducts, calculi, the obstruction of ducts, and biofilm might contribute to the intermittent positive cultures [22]. These reflect the complex microorganism environment in the prostate [23]. We believe that both limitations and difficulties in clinical trials (e.g.…”

Section: Discussionmentioning

confidence: 99%

Atypical Microorganisms in Expressed Prostatic Secretion from Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Microbiological Results from a Case-Control Study

Xiao

Ren²,

Lv³

et al. 2013

Urol Int

View full text Add to dashboard Cite

Objectives: To investigate the microorganisms in expressed prostatic secretions (EPS) of both chronic prostatitis patients and normal young male adults and to determine which microorganisms are associated with the degree of intraprostatic inflammation. Methods: Specific polymerase chain reaction (PCR) technology was performed to confirm Neisseria gonorrhoeae, Mycobacterium tuberculosis, Mycoplasma and Chlamydia trachomatis as well as human papilloma virus (HPV), herpes simplex virus type 2 (HSV-2) and cytomegalovirus (CMV). Universal primer PCR technology was carried out to detect 16S bacteria rDNA, followed by cloning and sequencing of the entire 16S rDNA product. Results: The total number of bacteria and/or viruses detected by PCR assays was significantly associated with disease severity (p < 0.001). The white blood cell count and lecithin level was significantly correlated with the number of detected bacteria and/or viruses (p = 0.001 and p = 0.046, respectively). 17 bacterial isolates were identified from 14 EPS samples by 16S rDNA sequencing. Conclusions: Various microorganisms including Ureaplasma urealyticum, C. trachomatis, CMV, HPV and HSV-2 were identified in the EPS from patients with type III prostatitis. HPV infection may be associated with the degree of intraprostatic inflammation.

show abstract

Section: Discussionmentioning

confidence: 99%

Atypical Microorganisms in Expressed Prostatic Secretion from Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Microbiological Results from a Case-Control Study

Xiao

Ren²,

Lv³

et al. 2013

Urol Int

View full text Add to dashboard Cite

show abstract

“…Overall, a statistically significant reduction in the NIH-CPSI total and domain scores was seen after treatment. However, no difference was recorded between the scores after treatment of patients who did or did not receive repeated prostatic massage [107]. The review concluded that the available studies do not provide high-quality evidence, due to the lack of randomised placebo/sham-controlled trials [106].…”

Section: Surgical Interventionmentioning

confidence: 99%

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Rees

Abrahams

Doble³

et al. 2015

BJU International

239

193

View full text Add to dashboard Cite

ObjectivesTo improve awareness and recognition of chronic bacterial prostatitis (CBP) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) among non-specialists and patients. To provide guidance to healthcare professionals treating patients with CBP and CP/CPPS, in both non-specialist and specialist settings. To promote efficient referral of care between nonspecialists and specialists and the involvement of the multidisciplinary team (MDT). Patients and MethodsThe guideline population were men with CBP or CP/CPPS (persistent or recurrent symptoms and no other urogenital pathology for ≥3 of the previous 6 months). Consensus recommendations for the guidelines were based on a search to identify literature on the diagnosis and management of CBP and CP/CPPS (published between 1999 and February 2014). A Delphi panel process was used where high-quality, published evidence was lacking. ResultsCBP and CP/CPPS can present with a wide range of clinical manifestations. The four main symptom domains are urogenital pain, lower urinary tract symptoms (LUTSvoiding or storage symptoms), psychological issues and sexual dysfunction. Patients should be managed according to their individual symptom pattern. Options for first-line treatment include antibiotics, a-adrenergic antagonists (if voiding LUTS are present) and simple analgesics. Repeated use of antibiotics, such as quinolones, should be avoided if there is no obvious symptomatic benefit from infection control or cultures do not support an infectious cause. Early use of treatments targeting neuropathic pain and/or referral to specialist services should be considered for patients who do not respond to initial measures. An MDT approach (urologists, pain specialists, nurse specialists, specialist physiotherapists, general practitioners, cognitive behavioural therapists/psychologists, and sexual health specialists) is recommended. Patients should be fully informed about the possible underlying causes and treatment options, including an explanation of the chronic pain cycle. ConclusionChronic prostatitis can present with a wide variety of signs and symptoms. Identification of individual symptom patterns and a symptom-based treatment approach are recommended. Further research is required to evaluate management options for CBP and CP/CPPS.

show abstract

“…Traditionally, therapies for CP/ CPPS include antibiotics, α-blockers, phytotherapy, and other medical agents (3)(4)(5)(6)(7). However, part of the patients have refractory symptoms despite multiple treatment approaches (8).…”

Section: Introductionmentioning

confidence: 99%

Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)

Zhao

Zhang

et al. 2009

Braz J Med Biol Res

View full text Add to dashboard Cite

Evaluation of prostatic massage in treatment of chronic prostatitis

Cited by 33 publications

References 9 publications

Atypical Microorganisms in Expressed Prostatic Secretion from Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Microbiological Results from a Case-Control Study

Atypical Microorganisms in Expressed Prostatic Secretion from Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Microbiological Results from a Case-Control Study

Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline

Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)

Contact Info

Product

Resources

About